UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

AXL in cancer: a modulator of drug resistance and therapeutic target

Journal of experimental & clinical cancer research, 2023-06, Vol.42 (1), p.148-148, Article 148

2023

Volltextzugriff (PDF)

Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK/eIF4E axis in non-small cell lung cancer

Cell death & disease, 2022-02, Vol.13 (2), p.129-129, Article 129

2022

Volltextzugriff (PDF)

USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1

Cell death & disease, 2021-11, Vol.12 (11), p.1051-1051, Article 1051

2021

Volltextzugriff (PDF)

Hyperprogression After Immune-Checkpoint Inhibitor Treatment: Characteristics and Hypotheses

Frontiers in oncology, 2020-04, Vol.10, p.515-515

2020

Volltextzugriff (PDF)

Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib

Cancer research (Chicago, Ill.), 2021-09, Vol.81 (18), p.4822-4834

2021

Volltextzugriff (PDF)

Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer

PloS one, 2020-02, Vol.15 (2), p.e0227768-e0227768

2020

Volltextzugriff (PDF)

Overexpressed p-S6 associates with lymph node metastasis and predicts poor prognosis in non-small cell lung cancer

BMC cancer, 2022-05, Vol.22 (1), p.564-564, Article 564

2022

Volltextzugriff (PDF)

Hyperprogressive Disease After Immunotherapy: A Case Report of Pulmonary Enteric Adenocarcinoma

Frontiers in oncology, 2022-03, Vol.12, p.799549

2022

Volltextzugriff (PDF)

miR-4634 augments the anti-tumor effects of RAD001 and associates well with clinical prognosis of non-small cell lung cancer

Scientific reports, 2020-08, Vol.10 (1), p.13079, Article 13079

2020

Volltextzugriff (PDF)

High expression of HSP60 and survivin predicts poor prognosis for oral squamous cell carcinoma patients

BMC oral health, 2023-09, Vol.23 (1), p.1-10, Article 629

2023

Volltextzugriff (PDF)

Comprehensive analysis of the mechanism and treatment significance of Mucins in lung cancer

Journal of experimental & clinical cancer research, 2020-08, Vol.39 (1), p.162-162, Article 162

2020

Volltextzugriff (PDF)

Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol

Molecular oncology, 2020-04, Vol.14 (4), p.882-895

2020

Volltextzugriff (PDF)

Increased expression of FAT4 suppress metastasis of lung adenocarcinoma through regulating MAPK pathway and associated with immune cells infiltration

Cancer medicine (Malden, MA), 2023-01, Vol.12 (2), p.1616-1629

2023

Volltextzugriff (PDF)

Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer

Diagnostic pathology, 2019-10, Vol.14 (1), p.108-108, Article 108

2019

Volltextzugriff (PDF)

Inflammatory Myofibroblastic Tumor of the Urinary Bladder: An 11-Year Retrospective Study From a Single Center

Frontiers in medicine, 2022-03, Vol.9, p.831952-831952

2022

Volltextzugriff (PDF)

The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer

Cancer Chemotherapy and Pharmacology, 2017-02, Vol.79 (2), p.227-231

2017

Volltextzugriff (PDF)

Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas

Critical reviews in oncology/hematology, 2024-01, Vol.193, p.104223-104223, Article 104223

2024

Volltextzugriff (PDF)

Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer

Journal of Cancer, 2017-01, Vol.8 (18), p.3856-3861

2017

Volltextzugriff (PDF)

Long non-coding RNAs associated with non-small cell lung cancer

Oncotarget, 2017-09, Vol.8 (40), p.69174-69184

2017

Volltextzugriff (PDF)

Overcoming acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589)

Cancer, 2020-05, Vol.126 (9), p.2024-2033

2020

Volltextzugriff (PDF)

ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib

Cancer, 2020-03, Vol.126 (6), p.1339-1350

2020

Volltextzugriff (PDF)

ERK inhibition effectively overcomes acquired resistance of EGFR-mutant NSCLC cells to osimertinib

Cancer, 2019-12, Vol.126 (6), p.1339-1350

2019

Volltextzugriff (PDF)

Abstract 1277: Honokiol, a natural product, overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1277-1277

2019

Volltextzugriff (PDF)

Efficacy of indocyanine green fluorescence‐guided inguinal lymph node dissection for penile cancer: a randomised trial

BJU international, 2024-04, Vol.133 (4), p.442-450

2024

Volltextzugriff (PDF)

G3BP1 Interact with JAK2 mRNA to Promote the Malignant Progression of Nasopharyngeal Carcinoma via Activating JAK2/STAT3 Signaling Pathway

International journal of biological sciences, 2024, Vol.20 (1), p.94-112

2024

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(89)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Physical Sciences
(37)
Astronomy & Astrophysics
(32)
Life Sciences & Biomedicine
(32)
Humans
(21)
Oncology
(21)
Gravitational Lensing: Micro
(16)
Microlenses
(16)
Prognosis
(15)
Planets
(14)
Proteins
(13)
Lung Cancer
(12)
Apoptosis
(11)
Gravitational Microlensing Exoplanet Detection
(11)
Tumors
(11)
Cell Line, Tumor
(10)
Gravitational Microlensing
(10)
Kinases
(10)
Medical Prognosis
(10)
Metastasis
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

AXL in cancer: a modulator of drug resistance and therapeutic target

Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK/eIF4E axis in non-small cell lung cancer

USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1

Hyperprogression After Immune-Checkpoint Inhibitor Treatment: Characteristics and Hypotheses

Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib

Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer

Overexpressed p-S6 associates with lymph node metastasis and predicts poor prognosis in non-small cell lung cancer

Hyperprogressive Disease After Immunotherapy: A Case Report of Pulmonary Enteric Adenocarcinoma

miR-4634 augments the anti-tumor effects of RAD001 and associates well with clinical prognosis of non-small cell lung cancer

High expression of HSP60 and survivin predicts poor prognosis for oral squamous cell carcinoma patients

Comprehensive analysis of the mechanism and treatment significance of Mucins in lung cancer

Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol

Increased expression of FAT4 suppress metastasis of lung adenocarcinoma through regulating MAPK pathway and associated with immune cells infiltration

Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer

Inflammatory Myofibroblastic Tumor of the Urinary Bladder: An 11-Year Retrospective Study From a Single Center

The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer

Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas

Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer

Long non-coding RNAs associated with non-small cell lung cancer

Overcoming acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589)

ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib

ERK inhibition effectively overcomes acquired resistance of EGFR-mutant NSCLC cells to osimertinib

Abstract 1277: Honokiol, a natural product, overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib

Efficacy of indocyanine green fluorescence‐guided inguinal lymph node dissection for penile cancer: a randomised trial

G3BP1 Interact with JAK2 mRNA to Promote the Malignant Progression of Nasopharyngeal Carcinoma via Activating JAK2/STAT3 Signaling Pathway

Suchergebnisse filtern